Hepion Pharmaceuticals, Inc.
HEPA· OTC
HEPAHepion Pharmaceuticals, Inc.
Filed Aug 14, 2018 · 10-Q · 45 days after period end · 0001104659-18-052012
| Metric | Q2 2018 | Q2 2017 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | -$4.03M | $2.05M | -$3.10M | -$168.16K |
| EPS Diluted | -$26.45 | $0.27 | -$0.36 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Hepion Pharmaceuticals, Inc. · CIK 1583771 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 14, 2018 · 45 d after period end
